1999
DOI: 10.1002/(sici)1096-8628(19990521)84:2<151::aid-ajmg12>3.3.co;2-k
|View full text |Cite
|
Sign up to set email alerts
|

Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
60
0
2

Year Published

2003
2003
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(62 citation statements)
references
References 0 publications
0
60
0
2
Order By: Relevance
“…Unfortunately, no nutrition inquiry was performed. Normal levels of serum folate have been reported by several studies (Christensen et al, 1999; Villarreal et al, 2001). The level of folate is probably not associated with NTDs in our population, which is different from findings by other authors (Gardiki‐Kouidou and Seller, 1988; Wild et al, 1994).…”
Section: Discussionmentioning
confidence: 72%
See 1 more Smart Citation
“…Unfortunately, no nutrition inquiry was performed. Normal levels of serum folate have been reported by several studies (Christensen et al, 1999; Villarreal et al, 2001). The level of folate is probably not associated with NTDs in our population, which is different from findings by other authors (Gardiki‐Kouidou and Seller, 1988; Wild et al, 1994).…”
Section: Discussionmentioning
confidence: 72%
“…Further studies focusing on the genetic analysis of the genes involved in homocysteine methionine metabolism are needed. An enzyme, methionine synthase, is also associated with homocysteine metabolism, and a polymorphism, a 2756A>G mutation, has been identified (Leclerc et al, 1996), but several studies have failed to demonstrate any association of this polymorphism with NTDs (Van der Put et al, 1997; Morrison et al, 1998; Christensen et al, 1999). Another enzyme, methionine synthase reductase, which is responsible for maintaining the methionine synthase in its active state, has recently been cloned (Leclerc et al, 1998).…”
Section: Discussionmentioning
confidence: 99%
“…These authors have speculated that maternal effects could reflect epigenetic processes like imprinting or maternal genotype effects in the intrauterine environment. Maternal effects have been described for other birth defects, particularly when gene–nutrient interactions are present [Christensen et al, 1999], such as the case of the maternal MTHFR genotype effect in the risk of NSCLP [Martinelli et al, 2001; Prescott et al, 2002; Jugessur et al, 2003; van Rooij et al, 2003]. Nevertheless, no epigenetic control has yet been demonstrated for NSCLP candidate genes.…”
Section: Discussionmentioning
confidence: 99%
“…These findings have led to the hypothesis that genetic defects in folate metabolism or transport may account for variations in individual susceptibility to NTD‐affected pregnancies. However, although some gene polymorphisms in folate transporters and folate‐pathway enzymes have been identified (Christensen et al, ; Beaudin and Stover, ), studies to date have provided no conclusive evidence that these genetic differences affect folate status (Beaudin and Stover, ). Together, these results highlight that folic acid appears to be a corrective, rather than causal factor, in the etiopathogenesis of NTDs (Wallingford et al, ).…”
Section: Introductionmentioning
confidence: 99%